Literature DB >> 12001187

Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR.

Chrysanthy Bili1, Aspasia Divane, Angela Apessos, Tassis Konstantinos, Athanasiadis Apostolos, Barbarigos Ioannis, Theodoropoulos Periklis, Lina Florentin.   

Abstract

OBJECTIVE: Quantitative fluorescence-polymerase chain reaction (QF-PCR) has recently been used for the detection of common chromosomal aneuploidies in prenatal diagnosis. Here we describe our experience in prenatal diagnosis of 1100 samples.
METHODS: Extraction of DNA was performed from amniotic fluid, chorionic villus samples (CVS), fetal blood and fetal tissue samples, using a simple, rapid protocol. Fluorescent multiplex PCR products of single tandem repeats (STRs) located on chromosomes 13, 18, 21, X and Y were then analyzed on an automated laser fluorescent sequencer. All samples were analyzed with at least two polymorphic markers for chromosomes 13, 18 and 21 and one for the X chromosome. The amelogenin locus was used for sexing. Analysis was performed twice on affected samples. When miscellaneous results were obtained extra markers were used.
RESULTS: We evaluated the usefulness of different markers in the Greek population. In a total of 1100 samples, 25 chromosome aberrations were identified, including trisomy 13, 18 and 21, XYY, triploidies 69,XXX and 69,XXY and one Turner mosaic. All results but three were consistent with conventional cytogenetic analysis. One mosaic was missed. Most bloodstained samples were successfully analyzed.
CONCLUSION: Successful analysis of a large number of prenatal samples proves QF-PCR to be an efficient adjunct in routine prenatal diagnosis. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001187     DOI: 10.1002/pd.301

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Screening for genetic disorders.

Authors:  Nicole Philip
Journal:  Childs Nerv Syst       Date:  2003-06-14       Impact factor: 1.475

2.  STR markers for detecting heterogeneity in Indian population.

Authors:  Shalu Jain; Inusha Panigrahi; Jayesh Sheth; Sarita Agarwal
Journal:  Mol Biol Rep       Date:  2011-05-17       Impact factor: 2.316

Review 3.  Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy.

Authors:  Chad D Markert; Anthony Atala; Jennifer K Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K Childers
Journal:  PM R       Date:  2009-06       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.